Sofia Angels Ventures – New Investment Press Release
Sofia Angels Ventures (SAV) is proud to announce its investment in Blue Longevity Clinic, a next-generation longevity and preventive health company set to open clinics in Athens, Sofia, and Istanbul in September 2025. The €2 million seed round was led by Eleven Ventures, with participation from SAV and prominent family offices across the region.
Founded by seasoned healthcare entrepreneur Ilian Grigorov (City Clinic, Blocks Health), Blue Longevity Clinic is on a mission to extend healthspan — the number of years lived in good health — through an integrated approach combining advanced diagnostics, evidence-based therapies, and proprietary digital tools.
A new frontier in healthcare
Blue Longevity Clinic stands at the intersection of three converging global trends: the rise of personalized medicine, the growing demand for preventive care, and the mainstreaming of longevity science. While most traditional health providers focus on treating symptoms, Blue Longevity seeks to delay or reverse age-related decline by targeting the root biological causes of aging.
The clinics will offer functional diagnostics (including genomics, microbiome analysis, and biological age testing), along with cutting-edge therapies such as Hyperbaric Oxygen Therapy (HBOT), Cryotherapy, Red Light Therapy, and AI-driven longevity planning. Patients will be supported by a medical team that blends clinical rigor with behavioral coaching via a mobile app that fosters sustainable lifestyle change.
Southeast Europe as a longevity hub
„Blue Longevity Clinic is creating the infrastructure for a longevity healthcare revolution in Southeast Europe — one of the fastest-growing out-of-pocket healthcare markets in the EU,“ said Milen Ivanov, Managing Partner at Sofia Angels Ventures. “We believe the timing is right for a shift from reactive to proactive health systems. This team brings the credibility, experience, and ambition to lead the movement.”
The founding team combines medical, operational, and entrepreneurial excellence. Alongside Grigorov, co-founders include Blagoy Palev, former banker and healthtech executive, and Dr. George Vissarakis, a rehabilitation medicine expert with decades of clinical experience in Greece and the UK.
A scalable, tech-enabled model
Beyond its physical clinics, Blue Longevity is building a digital ecosystem — including an AI-powered diagnostics engine, a wearable-integrated app, and a marketplace for longevity products — that will allow it to scale its approach regionally and globally. Inspired by the Blue Zones (regions where people live exceptionally long and healthy lives), the platform promotes a Mediterranean lifestyle, personalized care, and data-driven health optimization.
About Sofia Angels Ventures
Sofia Angels Ventures (SAV) is a €13M early-stage co-investment venture capital fund backed by the European Investment Fund (EIF), investing across Europe. The fund focuses on high-growth startups in HealthTech, AI, and the Future of Work, supporting globally ambitious founders.
SAV’s investment is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI), set up under the Investment Plan for Europe. EFSI aims to support financing and implementation of productive investments in the EU and ensure increased access to capital for innovative companies.
SAV’s investment in Blue Longevity Clinic reflects its continued commitment to backing visionary founders who are transforming how we live, work, and stay healthy.
June 2025
Sofia
